24 results
Drugs and Classes Associated with DILI and Type of Liver Injury

#Medications #Differential #DrugInduced #LiverInjury #Hepatology #Pharmacology
Drugs and Classes ... Liver Injury #Medications ... #LiverInjury #Hepatology ... #Pharmacology # ... Causes #DILI
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
Pathophysiology • Indications ... BetaBlockers #Cirrhosis #hepatology ... #management #pharmacology ... #indications #dosing
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
treatment #hcv #medications ... infectiousdisease #hepatology ... HepC #HepatitisC #Management ... #Pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology # ... treatment #medications ... decisionaid #cardiology #hematology
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Atopic Dermatitis ... After non-pharmacologic ... is the newest medication ... #Pharmacology # ... Dermatology #Management
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
therapy is non-pharmacologic ... the first line pharmacologic ... Topical #Treatment #Medications ... #Pharmacology # ... Dermatology #Management
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Tranexamic Acid - Indications ... and Pharmacology ... : Urine Common Uses ... #Pharmacology # ... hematology
Purpura - Differential Diagnosis Framework

Non-blanchable, dark red to purple, hemorrhagic skin lesions that result from leakage
• Secondary Causes ... deficiencies - PNH ... Pigmented Purpuric Dermatosis ... Differential #Diagnosis #hematology ... #rheumatology #
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
200ng/mL Best indications ... • Special cases ... Measurement #SLE #rheumatology ... #pharmacology # ... levels #lupus #management
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
risk factors, management ... #management #medications ... treatment #diagnosis #causes ... #eczema #dermatology ... corticosteroids in dermatology